Association of chronic inflammation and accelerated atherosclerosis among an indigenous black population with chronic kidney disease

被引:12
|
作者
Hassan, Muzamil Olamide [1 ]
Dix-Peek, Therese [2 ]
Duarte, Raquel [2 ]
Dickens, Caroline [2 ]
Naidoo, Sagren [1 ]
Vachiat, Ahmed [3 ]
Grinter, Sacha [3 ]
Manga, Pravin [3 ]
Naicker, Saraladevi [4 ]
机构
[1] Univ Witwatersrand, Div Nephrol, Dept Internal Med, Fac Hlth Sci, Johannesburg, South Africa
[2] Univ Witwatersrand, Dept Internal Med, Internal Med Res Lab, Fac Hlth Sci, Johannesburg, South Africa
[3] Univ Witwatersrand, Div Cardiol, Dept Internal Med, Fac Hlth Sci, Johannesburg, South Africa
[4] Univ Witwatersrand, Dept Internal Med, Fac Hlth Sci, Johannesburg, South Africa
来源
PLOS ONE | 2020年 / 15卷 / 07期
基金
新加坡国家研究基金会;
关键词
TOLL-LIKE RECEPTOR-4; SINGLE NUCLEOTIDE POLYMORPHISMS; INTIMA-MEDIA THICKNESS; ASP299GLY POLYMORPHISM; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; IMMUNE ACTIVATION; BINDING PROTEIN; TLR4; ENDOTOXEMIA;
D O I
10.1371/journal.pone.0232741
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction Inflammation plays a major role in the development of atherosclerosis and cardiovascular morbidity and mortality in chronic kidney disease (CKD) patients. Toll-like receptor-4 (TLR4) is a major receptor for lipopolysaccharides (endotoxin) and other ligands involved in the pathogenesis of inflammation. We determined whether endotoxin levels and the presence of TLR4 polymorphisms are associated with markers of inflammation and atherosclerosis among South African CKD patients. Materials and methods Endotoxin, lipopolysaccharide binding protein (LBP), serum CD14 (sCD14), interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1) and carotid intima media thickness (CIMT) were measured in 160 participants (120 CKD patients and 40 controls). Associations between endotoxins and CIMT in the presence of sCD14, IL-8 and MCP-1, were assessed using odds ratios. Participants were screened for the presence of Asp299Gly and Thr399Ile TLR4 polymorphisms, and CIMT and inflammatory markers were compared between subjects with and without TLR4 polymorphisms. Results Endotoxin levels correlated with sCD14 (r = 0.441, p<0.001) and MCP-1 (r = 0.388, p<0.001) levels while increased CIMT was associated with MCP-1 (r = 0.448, p<0.001), sCD14 levels (r = 0.476, p<0.001), LBP (r = 0.340, p<0.001), and IL-8 (r = 0.395, p<0.001). Atherosclerosis was associated with endotoxin levels (odds ratio: 4.95; 95% confidence interval: 2.52-9.73; p<0.001), and was predicted by higher serum levels of inflammatory markers. Analysis of patients with TLR4 polymorphisms showed reduced serum levels of inflammatory markers and CIMT values compared with the patients carrying the wild type TLR4 alleles. Conclusion The study demonstrated associations between circulating endotoxaemia, systemic inflammation and accelerated atherosclerosis among South African CKD patients, and showed that the atherogenic predictive power of endotoxaemia was significantly increased by the presence of elevated levels of inflammatory markers. Additional findings, which must be confirmed, suggest that TLR4 polymorphisms are associated with low levels of inflammatory markers and CIMT values.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Update on Inflammation in Chronic Kidney Disease
    Akchurin, Oleh M.
    Kaskel, Frederick
    BLOOD PURIFICATION, 2015, 39 (1-3) : 84 - 92
  • [42] Ischemia and inflammation on chronic kidney disease
    Tamaki, Nagara
    JOURNAL OF NUCLEAR CARDIOLOGY, 2019, 26 (02) : 441 - 442
  • [43] Bone, inflammation and chronic kidney disease
    Mazzaferro, Sandro
    De Martini, Natalia
    Rotondi, Silverio
    Tartaglione, Lida
    Urena-Torres, Pablo
    Bover, Jordi
    Pasquali, Marzia
    CLINICA CHIMICA ACTA, 2020, 506 : 236 - 240
  • [44] New Genetic Loci Associated With Chronic Kidney Disease in an Indigenous Australian Population
    Thomson, Russell J.
    McMorran, Brendan
    Hoy, Wendy
    Jose, Matthew
    Whittock, Lucy
    Thornton, Tim
    Burgio, Gaetan
    Mathews, John Duncan
    Foote, Simon
    FRONTIERS IN GENETICS, 2019, 10
  • [45] Atherosclerosis and Epigenetic Modifications in Chronic Kidney Disease
    Piko, Nejc
    Bevc, Sebastjan
    Hojs, Radovan
    Ekart, Robert
    NEPHRON, 2023, 147 (11) : 655 - 659
  • [46] Atherosclerosis Progression in Chronic Kidney Disease.
    Perez, Hernan A.
    Aballay, Laura
    Armando, Luis J.
    Spence, J. David
    Garcia, Nestor H.
    HYPERTENSION, 2017, 70
  • [47] Atherosclerosis in chronic kidney disease: the role of macrophages
    Valentina Kon
    MacRae F. Linton
    Sergio Fazio
    Nature Reviews Nephrology, 2011, 7 : 45 - 54
  • [48] The risk of atherosclerosis in patients with chronic kidney disease
    Olechnowicz-Tietz, Sylwia
    Gluba, Anna
    Paradowska, Anna
    Banach, Maciej
    Rysz, Jacek
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2013, 45 (06) : 1605 - 1612
  • [49] Links lipoproteins to chronic kidney disease and atherosclerosis
    Lu, Hong S.
    Kukida, Masayoshi
    Daugherty, Alan
    CURRENT OPINION IN LIPIDOLOGY, 2019, 30 (05) : 410 - 411
  • [50] Atherosclerosis in chronic kidney disease: the role of macrophages
    Kon, Valentina
    Linton, MacRae F.
    Fazio, Sergio
    NATURE REVIEWS NEPHROLOGY, 2011, 7 (01) : 45 - 54